On April 22, 2024, Benitec Biopharma Inc. closed the transaction. The company has received $40,000,018 from 17 investors pursuant to exemption provided under Regulation D. The company has paid placement agent fee of $2,400,001.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.37 USD | -6.48% | +12.65% | +159.13% |
Apr. 22 | Benitec Biopharma Inc. announced that it has received $40.000019 million in funding from a group of investors | CI |
Apr. 18 | Sector Update: Health Care Stocks Mixed in Late Afternoon Trading | MT |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
23.42 USD | +0.17% | +0.17% | 12.3B | ||
8.37 USD | -6.48% | +12.65% | 76.07M | ||
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+159.13% | 76.07M | |
+22.79% | 47.9B | |
+46.56% | 41.42B | |
-1.88% | 40.7B | |
-6.20% | 28.92B | |
+11.39% | 25.55B | |
-21.08% | 19.27B | |
-1.41% | 12.15B | |
+30.52% | 12.14B | |
-0.48% | 11.99B |
- Stock Market
- Equities
- BNTC Stock
- News Benitec Biopharma Inc.
- Benitec Biopharma Inc. announced that it has received $40.000019 million in funding from a group of investors